Skip to main content
. 2021 Aug 31;40(4):724–733. doi: 10.23876/j.krcp.20.260

Table 2.

Hemoglobin (Hb) variability by route of erythropoietin administration

Variable Intravenous group (n = 38) Subcutaneous group (n = 33) p-value
Hb of >12, <9 g/dL (n/visit) 0.27 ± 0.12 0.36 ± 0.19 0.03
Hb excursion (≥1.5) (n/visit) 0.20 ± 0.08 0.17 ± 0.12 0.27
Standard deviation of Hb 0.97 ± 0.23 1.02 ± 0.28 0.43
Residual standard deviation of Hb 0.90 ± 0.23 0.97 ± 0.36 0.31
Coefficient of Hb variation 0.10 ± 0.02 0.11 ± 0.03 0.15
ESA responsiveness index (U/kg/week/g/dL) 10.9 ± 3.0 11.7 ± 4.8 0.61

Data expressed as mean ± standard deviation

ESA, erythropoiesis-stimulating agent.